Matching-Adjusted Indirect Comparison of Blinatumomab vs. Inotuzumab Ozogamicin for Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia. [electronic resource]
Producer: 20200501Description: 950-961 p. digitalISSN:- 1865-8652
- Adult
- Antibodies, Bispecific -- administration & dosage
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Agents, Immunological -- administration & dosage
- Bone Marrow Examination -- methods
- Comparative Effectiveness Research
- Female
- Humans
- Inotuzumab Ozogamicin -- administration & dosage
- Male
- Middle Aged
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Remission Induction -- methods
- Secondary Prevention -- methods
- Survival Rate
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.